Kures, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults (NCT05114265) | Kures, Inc. | 2022-02-15 |
Track Kures, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.